末次正常时间超过24小时患者血管内取栓与药物治疗的功能与安全结局关联:SELECT Late研究
这项回顾性观察性队列研究纳入2012年7月至2021年12月美国、西班牙、澳大利亚和新西兰17个中心的301例末次正常时间超过24小时的大血管闭塞患者,比较血管内取栓与药物治疗。取栓组功能独立比例高于药物组(38% vs 10%;IPTW aOR 4.56),但症状性颅内出血风险升高(10.1% vs 1.7%;IPTW aOR 10.65),死亡率更低(26% vs 41%;IPTW aOR 0.49)。
要点
- 末次正常超过24小时大血管闭塞患者中,取栓组功能独立(mRS 0-2)比例为38%,药物组为10%(IPTW aOR 4.56,95%CI 2.28-9.09)。
- 取栓组症状性颅内出血发生率为10.1%,药物组为1.7%(IPTW aOR 10.65,95%CI 2.19-51.69)。
- 取栓组死亡率为26%,药物组为41%(IPTW aOR 0.49,95%CI 0.27-0.89)。
核心结论
- 在末次正常超过24小时的患者中,取栓与药物治疗相比功能独立几率更高,在倾向评分匹配亚组及存在错配的患者中结果一致,尽管症状性颅内出血几率增加。
- 研究结果支持在部分经过选择的超过24小时患者中取栓的可行性,但需要前瞻性研究确认。
研究设计与样本
- 回顾性观察性队列研究,纳入2012年7月至2021年12月美国、西班牙、澳大利亚和新西兰17个中心的患者。
- 共纳入301例颈内动脉或大脑中动脉(M1或M2段)闭塞且末次正常超过24小时接受取栓或药物治疗的患者。
- 采用倾向评分加权多变量logistic回归分析,并校正预设临床特征、灌注参数和/或ASPECTS,随后在1:1倾向评分匹配队列中重复分析。
主要发现
- 301例患者中位年龄69岁(IQR 59-81),女性149例;185例(61%)接受取栓,116例(39%)接受药物治疗。
- 校正分析中,取栓组功能独立比例为38%,药物组为10%(IPTW aOR 4.56;95%CI 2.28-9.09;P < .001)。
- 取栓组症状性颅内出血发生率为10.1%,药物组为1.7%(IPTW aOR 10.65;95%CI 2.19-51.69;P = .003)。
- 基于临床特征和ASPECTS匹配后,取栓组功能独立35% vs 药物组19%(aOR 3.14;95%CI 1.02-9.72;P = .047)。
- 基于临床特征和灌注参数匹配后,取栓组功能独立35% vs 药物组17%(aOR 4.17;95%CI 1.15-15.17;P = .03);基于临床特征、ASPECTS和灌注参数匹配后,取栓组45% vs 药物组21%(aOR 4.39;95%CI 1.04-18.53;P = .04)。
临床怎么用
- 研究结果支持在部分经过选择的末次正常超过24小时患者中取栓的可行性,但需要前瞻性研究确认。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The role of endovascular thrombectomy is uncertain for patients presenting beyond 24 hours of the time they were last known well. OBJECTIVE: To evaluate functional and safety outcomes for endovascular thrombectomy (EVT) vs medical management in patients with large-vessel occlusion beyond 24 hours of last known well. DESIGN, SETTING, AND PARTICIPANTS: This retrospective observational cohort study enrolled patients between July 2012 and December 2021 at 17 centers across the United States, Spain, Australia, and New Zealand. Eligible patients had occlusions in the internal carotid artery or middle cerebral artery (M1 or M2 segment) and were treated with EVT or medical management beyond 24 hours of last known well. INTERVENTIONS: Endovascular thrombectomy or medical management (control). MAIN OUTCOMES AND MEASURES: Primary outcome was functional independence (modified Rankin Scale score 0-2). Mortality and symptomatic intracranial hemorrhage (sICH) were safety outcomes. Propensity score (PS)-weighted multivariable logistic regression analyses were adjusted for prespecified clinical characteristics, perfusion parameters, and/or Alberta Stroke Program Early CT Score (ASPECTS) and were repeated in subsequent 1:1 PS-matched cohorts. RESULTS: Of 301 patients (median [IQR] age, 69 years [59-81]; 149 female), 185 patients (61%) received EVT and 116 (39%) received medical management. In adjusted analyses, EVT was associated with better functional independence (38% vs control, 10%; inverse probability treatment weighting adjusted odds ratio [IPTW aOR], 4.56; 95% CI, 2.28-9.09; P < .001) despite increased odds of sICH (10.1% for EVT vs 1.7% for control; IPTW aOR, 10.65; 95% CI, 2.19-51.69; P = .003). This association persisted after PS-based matching on (1) clinical characteristics and ASPECTS (EVT, 35%, vs control, 19%; aOR, 3.14; 95% CI, 1.02-9.72; P = .047); (2) clinical characteristics and perfusion parameters (EVT, 35%, vs control, 17%; aOR, 4.17; 95% CI, 1.15-15.17; P = .03); and (3) clinical characteristics, ASPECTS, and perfusion parameters (EVT, 45%, vs control, 21%; aOR, 4.39; 95% CI, 1.04-18.53; P = .04). Patients receiving EVT had lower odds of mortality (26%) compared with those in the control group (41%; IPTW aOR, 0.49; 95% CI, 0.27-0.89; P = .02). CONCLUSIONS AND RELEVANCE: In this study of treatment beyond 24 hours of last known well, EVT was associated with higher odds of functional independence compared with medical management, with consistent results obtained in PS-matched subpopulations and patients with presence of mismatch, despite increased odds of sICH. Our findings support EVT feasibility in selected patients beyond 24 hours. Prospective studies are warranted for confirmation.
引用
- Sarraj A, Kleinig TJ, Hassan AE, et al. Association of Endovascular Thrombectomy vs Medical Management With Functional and Safety Outcomes in Patients Treated Beyond 24 Hours of Last Known Well: The SELECT Late Study. JAMA Neurol. 2023. PMID: 36574257. doi:10.1001/jamaneurol.2022.4714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。